27983510|t|Comparison of Leishmania typing results obtained from 16 European clinical laboratories in 2014
27983510|a|Leishmaniasis is endemic in southern Europe, and in other European countries cases are diagnosed in travellers who have visited affected areas both within the continent and beyond. Prompt and accurate diagnosis poses a challenge in clinical practice in Europe. Different methods exist for identification of the infecting Leishmania species. Sixteen clinical laboratories in 10 European countries, plus Israel and Turkey, conducted a study to assess their genotyping performance. DNA from 21 promastigote cultures of 13 species was analysed blindly by the routinely used typing method. Five different molecular targets were used, which were analysed with PCR-based methods. Different levels of identification were achieved, and either the Leishmania subgenus, species complex, or actual species were reported. The overall error rate of strains placed in the wrong complex or species was 8.5%. Various reasons for incorrect typing were identified. The study shows there is considerable room for improvement and standardisation of Leishmania typing. The use of well validated standard operating procedures is recommended, covering testing, interpretation, and reporting guidelines. Application of the internal transcribed spacer 1 of the rDNA array should be restricted to Old World samples, while the heat-shock protein 70 gene and the mini-exon can be applied globally.
27983510	0	10	Comparison	T052	C1707455
27983510	14	24	Leishmania	T204	C1095819
27983510	25	31	typing	T059	C0430416
27983510	32	39	results	T034	C0456984
27983510	40	48	obtained	T169	C1301820
27983510	57	65	European	T083	C0015176
27983510	66	87	clinical laboratories	T073,T093	C1551301
27983510	96	109	Leishmaniasis	T047	C0023281
27983510	113	120	endemic	UnknownType	C0544083
27983510	124	139	southern Europe	T083	C0037724
27983510	154	162	European	T083	C0015176
27983510	163	172	countries	T083	C0454664
27983510	173	178	cases	T081	C0021149
27983510	183	192	diagnosed	T033	C0011900
27983510	196	206	travellers	T097	C0335278
27983510	224	238	affected areas	T033	C1879646
27983510	244	250	within	T082	C0332285
27983510	255	264	continent	T083	C0454690
27983510	277	283	Prompt	T080	C0205556
27983510	288	296	accurate	T080	C0443131
27983510	297	306	diagnosis	T033	C0011900
27983510	328	345	clinical practice	T170	C2986419
27983510	349	355	Europe	T083	C0015176
27983510	357	366	Different	T080	C1705242
27983510	367	374	methods	T170	C0025663
27983510	375	380	exist	T077	C2987476
27983510	385	399	identification	T080	C0205396
27983510	407	416	infecting	T033	C0439663
27983510	417	427	Leishmania	T204	C1095819
27983510	428	435	species	T185	C1705920
27983510	445	466	clinical laboratories	T073,T093	C1551301
27983510	473	481	European	T083	C0015176
27983510	482	491	countries	T083	C0454664
27983510	498	504	Israel	T083	C0022271
27983510	509	515	Turkey	T083	C0041400
27983510	529	534	study	T062	C2603343
27983510	551	561	genotyping	T059	C1285573
27983510	562	573	performance	T052	C1882330
27983510	575	578	DNA	T114,T123	C0012854
27983510	587	608	promastigote cultures	T204	C0684063
27983510	615	622	species	T185	C1705920
27983510	627	635	analysed	T062	C0936012
27983510	636	643	blindly	T080	C0205556
27983510	651	660	routinely	T080	C0205547
27983510	666	672	typing	T059	C0430416
27983510	673	679	method	T170	C0025663
27983510	686	695	different	T080	C1705242
27983510	696	713	molecular targets	T104,T120	C1513403
27983510	736	744	analysed	T062	C0936012
27983510	750	759	PCR-based	T063	C0032520
27983510	760	767	methods	T170	C0025663
27983510	769	778	Different	T080	C1705242
27983510	779	785	levels	T080	C0441889
27983510	789	803	identification	T080	C0205396
27983510	809	817	achieved	T033	C0432600
27983510	834	844	Leishmania	T204	C1095819
27983510	845	853	subgenus	T077	C1883697
27983510	855	862	species	T185	C1705920
27983510	882	889	species	T185	C1705920
27983510	895	903	reported	T170	C0684224
27983510	909	916	overall	T080	C1561607
27983510	917	922	error	T080	C0743559
27983510	923	927	rate	T081	C1521828
27983510	931	938	strains	T001	C1518614
27983510	953	958	wrong	T080	C3827420
27983510	970	977	species	T185	C1705920
27983510	996	1003	reasons	T078	C0392360
27983510	1008	1017	incorrect	T080	C3827420
27983510	1018	1024	typing	T059	C0430416
27983510	1030	1040	identified	T080	C0205396
27983510	1046	1051	study	T062	C2603343
27983510	1067	1079	considerable	T080	C0205556
27983510	1089	1100	improvement	T077	C2986411
27983510	1105	1120	standardisation	T062	C0038136
27983510	1124	1134	Leishmania	T204	C1095819
27983510	1135	1141	typing	T059	C0430416
27983510	1159	1168	validated	T062	C1519941
27983510	1169	1198	standard operating procedures	T077	C1710183
27983510	1202	1213	recommended	T078	C0034866
27983510	1224	1231	testing	T169	C0039593
27983510	1233	1247	interpretation	T170	C0459471
27983510	1253	1262	reporting	T058	C0700287
27983510	1263	1273	guidelines	T170	C0162791
27983510	1294	1302	internal	T082	C0205102
27983510	1303	1314	transcribed	T080	C0205556
27983510	1315	1323	spacer 1	T114,T123	C0887858
27983510	1331	1335	rDNA	T114	C0012931
27983510	1336	1341	array	T075	C0600597
27983510	1352	1362	restricted	T169	C0443288
27983510	1366	1375	Old World	T080	C0205556
27983510	1376	1383	samples	T077	C2347026
27983510	1395	1421	heat-shock protein 70 gene	T028	C1415755
27983510	1430	1439	mini-exon	T114,T123	C0026163
27983510	1447	1454	applied	T169	C4048755
27983510	1455	1463	globally	T080	C2348867